Address
Novo A/S
19 Tuborg Havnevej
2900 Hellerup
Denmark
Website
Recent investment activity
KANDO id: 30981
Relation
Renamed to
Funding rounds
Investment preferences
Investment activity status
Not investing
Selected investments
Displaying 1 - 25 of 28Company | Profile | Country | Date | Funding | ||
---|---|---|---|---|---|---|
Amira Pharmaceuticals Inc | A small molecule pharmaceutical company focused on the discovery and early development of compounds. | N/A | ||||
Amira Pharmaceuticals Inc | A small molecule pharmaceutical company focused on the discovery and early development of compounds. | N/A | ||||
Asante Solutions Inc | Developing a disposable drug delivery system which initially will be used for insulin delivery for Type I diabetics. | N/A | ||||
Cabrellis Pharmaceuticals Corp | Development of important therapies for the treatment of cancer | Series A | ||||
Conforma Therapeutics Corp | Novel drugs company for the selective treatment of cancer. | N/A | ||||
Delenex Therapeutics AG | Series A | |||||
Gloucester Pharmaceuticals Inc | N/A | |||||
Imagen Biotech Inc | N/A | |||||
Inogen Inc | Developer and manufacturer of homecare products and services for oxygen therapy patients. | N/A | ||||
Light Sciences Oncology Inc | Drug-device cancer therapy | Series A | ||||
Logical Therapeutics Inc | An early stage biotechnology company | N/A | ||||
Lux Biosciences Inc | Clinical stage biotechnology company specializing in the development and commercialization of innovative medications for serious ophthalmic diseases. | N/A | ||||
MediQuest Therapeutics Inc | A specialty pharmaceutical company developing topical therapies to treat patients suffering from inflammatory and infectious diseases. | N/A | ||||
NeuroTherapeutics Pharma Inc | N/A | |||||
Ophthotech Corp | Clinical-stage biotechnology company, engages in developing and commercializing therapies for wet and dry age-related macular degeneration. | N/A | ||||
Panmira Pharmaceuticals LLC | Pharmaceutical company for inflammatory diseases. | N/A | ||||
ProteinSimple | ProteinSimple's goal is simply to help researchers gain a better understanding of proteins and their role in disease. | Series F | ||||
ProteinSimple | ProteinSimple's goal is simply to help researchers gain a better understanding of proteins and their role in disease. | Series C | ||||
PTC Therapeutics Inc | Biopharmaceutical company. | N/A | ||||
Santaris Pharma AS | Venture | |||||
Symphogen | Series F | |||||
Symphogen | Series D | |||||
Synosia Therapeutics | Develops innovative treatments for disorders of the central nervous system | N/A | ||||
Tobira Therapeutics Inc | Dedicated to the clinical development of antiviral products | Series B | ||||
Altheos Inc | A drug development company focused on next generation intraocular pressure (IOP) lowering agents for glaucoma and ocular hypertension. | Series A |